Vitara Biomedical develops a therapeutic platform to support premature infants.
Vitara Biomedical has raised $50.0M in total funding. The most recent round was Series B. The last funding was announced in November 2024.
Vitara Biomedical's investors include Khosla Ventures, Sands Capital Ventures, First Spark Ventures, Google Ventures, The Children's Hospital of Philadelphia.
Vitara Biomedical is headquartered in Philadelphia, United States.
Vitara Biomedical develops a therapeutic platform to support premature infants.
Vitara Biomedical is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Vitara Biomedical — Funding & Investors." VCBacked, November 18, 2024, https://www.vcbacked.co/company/vitara-biomedical. Accessed July 19, 2026.
VCBacked. (2024). Vitara Biomedical — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/vitara-biomedical
{{cite web |title=Vitara Biomedical — Funding & Investors |url=https://www.vcbacked.co/company/vitara-biomedical |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated